Medicaid Expansion Linked To Hypertension, Glucose Improvement

Medicaid Expansion Linked To Hypertension, Glucose Improvement

Medicaid expansion linked to hypertension, glucose improvement. New research shows that control measures for blood pressure and glucose are found effective in expansion states compared with non-expansion states.

According to the research, blood pressure and glucose control of Black and Hispanic residents are improved.

As part of the AC the Affordable Care Act (ACA), U.S. states received the option of expanding Medicaid coverage to more people for eliminating the number of people without health insurance.

Currently, 12 states have not expanded Medicaid eligibility.

A new study shows that improvements in blood pressure and glucose control measures are greatest in states participating in Medicaid expansion.

Monitoring blood pressure and glucose levels is difficult for the management of hypertension and diabetes, respectively.

The Centers for Disease Control and Prevention (CDC) states that out of the 108 million U.S. adults with high blood pressure, just 1 in 4 have their condition under control. This puts them at elevated risk of heart attack and stroke.

The latest study discovered that over the 5-year period, expansion states saw an overall 1.61 PP comparative improvement in blood pressure control and a 1.84 PP improvement in glucose control.

This study appears in the journal JAMA Health Forum.

“Our results suggest that over the longer run, expanding Medicaid eligibility may improve key chronic disease health outcomes for low-income, marginalized populations, which is an important consideration for the 12 states that have not yet adopted Medicaid expansion,” lead author of the study Dr. Megan Cole Brahim said.